A promising codrug of nicotinic acid and ibuprofen for managing dyslipidemia. I: synthesis and in vitro evaluation.
about
A promising codrug of nicotinic acid and ibuprofen for managing dyslipidemia. I: synthesis and in vitro evaluation.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
A promising codrug of nicotini ...... hesis and in vitro evaluation.
@en
A promising codrug of nicotini ...... hesis and in vitro evaluation.
@nl
type
label
A promising codrug of nicotini ...... hesis and in vitro evaluation.
@en
A promising codrug of nicotini ...... hesis and in vitro evaluation.
@nl
prefLabel
A promising codrug of nicotini ...... hesis and in vitro evaluation.
@en
A promising codrug of nicotini ...... hesis and in vitro evaluation.
@nl
P2093
P2860
P1476
A promising codrug of nicotini ...... hesis and in vitro evaluation.
@en
P2093
Amjad M Qandil
Bassam M Tashtoush
Fatima Z Abu Zanat
P2860
P304
P356
10.3109/03639045.2011.560155
P407
P577
2011-03-14T00:00:00Z